Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
76,991,404
-
Total 13F shares
-
6,121,388
-
Share change
-
-6,661,330
-
Total reported value
-
$8,447,399
-
Price per share
-
$1.38
-
Number of holders
-
53
-
Value change
-
-$8,179,669
-
Number of buys
-
15
-
Number of sells
-
38
Institutional Holders of Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) as of Q1 2019
As of 31 Mar 2019,
Clearside Biomedical, Inc. - Common Stock, $0.001 par value (CLSD) was held by
53 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,121,388 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, BOOTHBAY FUND MANAGEMENT, LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, GSA CAPITAL PARTNERS LLP, SIGNATUREFD, LLC, FIRST MANHATTAN CO, and Tekla Capital Management LLC.
This page lists
53
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.